Market Exclusive

Analyst Activity – Royal Bank of Canada Lowers Its Price Target On NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX) to

Analyst Ratings For NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX)

Today, Royal Bank of Canada lowered its price target on NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX) to per share.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX)
NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX) has insider ownership of 7.30% and institutional ownership of 72.15%.

Recent Trading Activity for NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX)
Shares of NASDAQ:AGRX – Agile Therapeutics closed the previous trading session at 0.71 up +0.02 2.90% with 0.699999988079071 shares trading hands.

Exit mobile version